Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Operating Margin (2016 - 2025)

Historic Operating Margin for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to 234.77%.

  • Jaguar Health's Operating Margin fell 11200.0% to 234.77% in Q3 2025 from the same period last year, while for Sep 2025 it was 278.52%, marking a year-over-year increase of 99500.0%. This contributed to the annual value of 263.76% for FY2024, which is 875500.0% up from last year.
  • Latest data reveals that Jaguar Health reported Operating Margin of 234.77% as of Q3 2025, which was down 11200.0% from 268.78% recorded in Q2 2025.
  • Jaguar Health's 5-year Operating Margin high stood at 192.82% for Q4 2022, and its period low was 3007.79% during Q2 2021.
  • In the last 5 years, Jaguar Health's Operating Margin had a median value of 314.16% in 2022 and averaged 546.08%.
  • Its Operating Margin has fluctuated over the past 5 years, first plummeted by -27409500bps in 2021, then surged by 27859800bps in 2022.
  • Over the past 5 years, Jaguar Health's Operating Margin (Quarter) stood at 520.29% in 2021, then surged by 63bps to 192.82% in 2022, then crashed by -70bps to 328.57% in 2023, then increased by 29bps to 232.46% in 2024, then dropped by -1bps to 234.77% in 2025.
  • Its Operating Margin was 234.77% in Q3 2025, compared to 268.78% in Q2 2025 and 425.52% in Q1 2025.